Free Trial

Abrdn Life Sciences Investors (HQL) SEC Filings & 10K Form

Abrdn Life Sciences Investors logo
$14.29 +0.08 (+0.56%)
(As of 11/20/2024 ET)

Recent Abrdn Life Sciences Investors SEC Filings

DateFilerForm TypeView
08/28/2024
1:07 PM
Abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
08/27/2024
1:46 PM
Abrdn Life Sciences Investors (Issuer)
Maher Bill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
9:46 AM
ABRDN ASIA-PACIFIC INCOME FUND, INC. (Filer)
ABRDN AUSTRALIA EQUITY FUND, INC. (Filer)
ABRDN EMERGING MARKETS EQUITY INCOME FUND, INC. (Filer)
abrdn Funds (Filer)
abrdn Global Dynamic Dividend Fund (Filer)
ABRDN GLOBAL INCOME FUND, INC. (Filer)
abrdn Global Infrastructure Income Fund (Filer)
abrdn Global Premier Properties Fund (Filer)
abrdn Healthcare Investors (Filer)
abrdn Healthcare Opportunities Fund (Filer)
abrdn Income Credit Strategies Fund (Filer)
ABRDN JAPAN EQUITY FUND, INC. (Filer)
Abrdn Life Sciences Investors (Filer)
abrdn National Municipal Income Fund (Filer)
abrdn Total Dynamic Dividend Fund (Filer)
abrdn World Healthcare Fund (Filer)
Form 40-17G
07/18/2024
1:56 PM
Abrdn Life Sciences Investors (Issuer)
DiMartino Rose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
10:22 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:36 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
2:18 PM
Abrdn Life Sciences Investors (Issuer)
Nichols Rebecca Suzanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
2:28 PM
Abrdn Life Sciences Investors (Issuer)
Taggart Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2024
12:59 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
1:34 PM
Abrdn Life Sciences Investors (Filer)
Form N-CSRS
06/10/2024
7:45 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:09 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:11 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
8:15 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
05/31/2024
2:08 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
8:13 AM
Abrdn Life Sciences Investors (Filer)
Form DEFA14A
05/23/2024
6:41 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
11:34 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
12:50 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
9:31 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:50 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
9:52 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
04/26/2024
10:40 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
7:00 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:12 PM
Abrdn Life Sciences Investors (Filer)
Form DEF 14A
04/22/2024
2:08 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
7:05 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2024
7:32 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
04/12/2024
8:20 AM
Abrdn Life Sciences Investors (Issuer)
Goetz Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
11:38 AM
Abrdn Life Sciences Investors (Issuer)
Tse Loretta (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/29/2024
11:37 AM
Abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
02/07/2024
6:55 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
01/12/2024
10:41 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
01/04/2024
1:23 PM
Abrdn Life Sciences Investors (Issuer)
Reit Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:34 PM
Abrdn Life Sciences Investors (Issuer)
Maher Bill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
6:54 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D
12/22/2023
1:12 PM
Abrdn Life Sciences Investors (Issuer)
Ritchie Ben (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2023
1:15 PM
Abrdn Life Sciences Investors (Issuer)
Duitz Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2023
9:57 AM
Abrdn Life Sciences Investors (Filer)
Form N-CEN
Annual Report for Registered Investment Companies
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:HQL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners